Name: Episode 32: Champix / Varenicline recall by NPS MedicineWise
Duration: 6 min 55 s
Description: In this episode, NPS MedicineWise educational visitor and pharmacist Kara Joyce interviews NPS MedicineWise medical advisor and GP Dr Anna Samecki to discuss the recent TGA alert around varenicline (marketed as Champix) and the implications for practice.

In this episode, NPS MedicineWise educational visitor and pharmacist Kara Joyce interviews NPS MedicineWise medical advisor and GP Dr Anna Samecki to discuss the recent TGA alert around varenicline (marketed as Champix) and the implications for practice.

Episode 32: Champix / Varenicline recall

In this episode, Dr Caroline West speaks with GP Registrar Dr Rebecca Davison, Nurse Jamie Maney and Sarah about ways to build engagement with young people with mental health issues in Aboriginal and Torres Strait Islander communities.

Episode 50: Mental health in Aboriginal and Torres Strait Islander young people By NPS MedicineWise is licensed under a  Creative Commons License.

Episode 50: Mental health in Aboriginal and Torres Strait Islander young people

In this episode Dr Anna Samecki talks with Melissa Black, a clinical psychologist from the Black Dog Institute. They discuss why it’s important for healthcare workers to proactively look after their own mental health, when to seek professional help, some simple ways to manage stress, and some of the resources available including The Essential Network (TEN), an e-health hub for healthcare workers. 

Further reading:
The Black Dog Institute: www.blackdoginstitute.org.au/ 
TEN - The Essential Network for Health Professionals: www.blackdoginstitute.org.au/ten/

Other NPSmedicinewise podcasts: www.nps.org.au/podcast

Episode 16: Mental Health For Health Professionals

In this episode Steve Morris interviews Dr Robert Herkes, Chief Medical Officer with the Australian Commission on Safety and Quality in Health Care and past Director of Intensive Care at the Royal Prince Alfred Hospital in Sydney. They discuss the ways in which the Commission has been supporting clinicians during COVID-19 and touch on some of the important lessons learned as a result of the pandemic. They also discuss why medication safety has proved to be such a difficult challenge over the years, and invite listeners to hear more at an upcoming panel discussion at the virtual National Medicines Symposium (NMS) 2020 to be held on Monday 7 December.
Further reading:
The Australian Commission on Safety and Quality in Health Care: www.safetyandquality.gov.au 
National Medicines Symposium (NMS) 2020: www.nps.org.au/nms2020

Other NPSmedicinewise podcasts: www.nps.org.au/podcast

Episode 17: Supporting clinicians to provide safe and quality health care

In this episode Dr Anna Samecki talks with accredited pharmacist Kara Joyce, who has been overseeing the new NPS MedicineWise program on Dementia and changed behaviours: a person-centred approach. 

They discuss the main issues facing aged care, specifically from a dementia and changed behaviours perspective, the impact of COVID-19 on this space, the importance of person-centred care, and what resources are available for health professionals to support consumers, their families and carers.

Episode 18: Dementia and changed behaviours: a person-centred approach

In this special edition of the NPS MedicineWise podcast, Dr Jill Thistlethwaite talks with Associate Professor Michael Vagg, pain physician and Dean of the Faculty of Pain Medicine Australian and New Zealand College of Anaesthetists (ANZCA) and Mr Don Firth, a member of Painaustralia’s Consumer Advisory Group, about the challenges involved in tapering opioids. They discuss the practical aspects of tapering, drawing from their different experiences, and sharing examples from clinical practice.

This podcast was developed with funding from the Therapeutic Goods Administration, Australian Government Department of Health.

Episode 19: Tapering opioids in partnership with patients with chronic non-cancer pain

In this episode Dr Anna Samecki talks with Theresa Flavin, who has been living with dementia for many years. Theresa gives a powerful insight into how it feels being on ‘the other side’ and offers a unique patient perspective on dementia and changed behaviour care.

Episode 22: A lived experience of dementia and changed behaviours

In this episode, recorded on 17 February 2021, NPS MedicineWise CEO Adj A/Prof Steve Morris is joined by the head of the Therapeutic Goods Administration (TGA) Adj Prof John Skerritt to hear the latest information about COVID-19 vaccination in Australia, which is rolling out from this month. They discuss how the TGA makes decisions about which vaccines to approve in terms of both safety and efficacy, and how potential adverse events from the vaccines will be monitored as the vaccine is rolled out. 

This information was current as at 17 February 2021. For up to date information please visit our Further Reading links.

Episode 23: Update on COVID-19 vaccines – February 2021

Independent, not-for-profit and evidence-based, NPS MedicineWise provides practical tools and information about medicines, health conditions and medical tests to help individuals and health professionals make better health decisions.

Episode 32: Champix / Varenicline recall

NPS MedicineWise

Related tracks